US2023381126A1PendingUtilityA1
Metallo-liothyronine
Est. expiryApr 4, 2038(~11.7 yrs left)· nominal 20-yr term from priority
A61K 31/198A61K 33/00A61K 33/06A61K 33/24A61K 33/30A61K 33/34A61K 47/42A61K 47/547C07F 3/003A61K 47/52A61P 5/14
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to supramolecular metal coordinated liothyronine (triiodothyronine, T3) compositions, methods of preparing such compositions, methods of purifying and formulating supramolecular metal coordinated liothyronine, and methods of treating hypothyroidism and other disease states using such compositions.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A supramolecular metal coordination complex according to formula I:
[M x D o A p W q ] n , wherein:
M is a metal atom;
D is a biologically active moiety that comprises at least two functional groups that are capable of coordinating to a divalent metal;
A is a second biologically active moiety or adjuvant;
W is H 2 O;
x is an integer from 1 to 10;
o is an integer from 1 to 10;
a p to x ratio is from about 1 to 1000 to about 1000 to 1;
q is zero or an integer from 1 to 20; and
n is an integer greater than or equal to 2.Join the waitlist — get patent alerts
Track US2023381126A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.